Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients

Detalles Bibliográficos
Autores principales: Santini, Valeria, Fenaux, Pierre, Giagounidis, Aristoteles, Platzbecker, Uwe, List, Alan F., Haferlach, Torsten, Zhong, Jim, Wu, Chengqing, Mavrommatis, Konstantinos, Beach, C. L., MacBeth, Kyle J., Almeida, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932918/
https://www.ncbi.nlm.nih.gov/pubmed/32661294
http://dx.doi.org/10.1038/s41375-020-0961-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932918/
https://www.ncbi.nlm.nih.gov/pubmed/32661294
http://dx.doi.org/10.1038/s41375-020-0961-3

Ejemplares similares